The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Inhibition of osteoblastic bone formation by nuclear factor-κB
Open accessAbstract
An imbalance in bone formation relative to bone resorption results in the net bone loss that occurs in osteoporosis and inflammatory bone diseases. Although it is well known how bone resorption is stimulated, the molecular mechanisms that mediate impaired bone formation are poorly understood. Here we show that the time- and stage-specific inhibition of endogenous inhibitor of κB kinase (IKK)–nuclear factor-κB (NF-κB) in differentiated osteoblasts substantially increases trabecular bone mass and bone mineral density without affecting osteoclast activities in young mice. Moreover, inhibition of IKK–NF-κB in differentiated osteoblasts maintains bone formation, thereby preventing osteoporotic bone loss induced by ovariectomy in adult mice. Inhibition of IKK–NF-κB enhances the expression of Fos-related antigen-1 (Fra-1), an essential transcription factor involved in bone matrix formation in vitro and in vivo. Taken together, our results suggest that targeting IKK–NF-κB may help to promote bone formation in the treatment of osteoporosis and other bone diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Self-citationPathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Self-citationNF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924
Self-citationNF-κB signaling pathways in mammalian and insect innate immunity
Silverman, N., & Maniatis, T. (2001) · Genes & Development · doi:10.1101/gad.909001 · Cited by 907
A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M., & Karsenty, G. (1999) · Genes & Development · doi:10.1101/gad.13.8.1025 · Cited by 774
Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., & Franzoso, G. (2001) · Nature · doi:10.1038/35104560 · Cited by 732
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z.-H., & Miyamoto, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00895-x · Cited by 560
Ge, C., Xiao, G., Jiang, D., & Franceschi, R. T. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610046 · Cited by 507
Self-citationJimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1054 · Cited by 501
Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML Factors
Lian, J. B., Javed, A., Zaidi, S. K., Lengner, C., Montecino, M., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.10 · Cited by 442
Pathophysiology of Age-Related Bone Loss and Osteoporosis
Khosla, S., & Riggs, B. L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.009 · Cited by 376
The role of the immune system in the pathophysiology of osteoporosis
Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 359
Yamashita, M., Ying, S.-X., Zhang, G.-M., Li, C., Cheng, S. Y., Deng, C.-X., & Zhang, Y. E. (2005) · Cell · doi:10.1016/j.cell.2005.01.035 · Cited by 355
Building bone to reverse osteoporosis and repair fractures
Khosla, S., Westendorf, J. J., & Oursler, M. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33612 · Cited by 353
Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis
Sabatakos, G., Sims, N. A., Chen, J., Aoki, K., Kelz, M. B., Amling, M., Bouali, Y., Mukhopadhyay, K., Ford, K., Nestler, E. J., et al. (2000) · Nature Medicine · doi:10.1038/79683 · Cited by 339
Park, B. K., Zhang, H., Zeng, Q., Dai, J., Keller, E. T., Giordano, T., Gu, K., Shah, V., Pei, L., Zarbo, R. J., et al. (2007) · Nature Medicine · doi:10.1038/nm1519 · Cited by 325
Self-citationIncreased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1
Jochum, W., David, J.-P., Elliott, C., Wutz, A., Plenk, H., Matsuo, K., & Wagner, E. F. (2000) · Nature Medicine · doi:10.1038/79676 · Cited by 311
Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042081 · Cited by 252
Genetic control of skeletal development
Wagner, E. F., & Karsenty, G. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00228-8 · Cited by 229
NF-κB activity in transgenic mice: developmental regulation and tissue specificity
Schmidt-Ullrich, R., Mémet, S., Lilienbaum, A., Feuillard, J., Raphaël, M., & Israël, A. (1996) · Development · doi:10.1242/dev.122.7.2117 · Cited by 226
Zelzer, E., & Olsen, B. R. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)65006-x · Cited by 224
Tang, E. D., Wang, C.-Y., Xiong, Y., & Guan, K.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303389200 · Cited by 205
Self-citationThe Fos‐related antigen Fra‐1 is an activator of bone matrix formation
Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M., & Wagner, E. F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600282 · Cited by 198
Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in Vivo
Frendo, J., Xiao, G., Fuchs, S., Franceschi, R. T., Karsenty, G., & Ducy, P. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30509 · Cited by 104
Self-citationReuther-Madrid, J. Y., Kashatus, D. F., Chen, S., Li, X., Westwick, J. K., Davis, R. J., Earp, H. S., Wang, C.-Y., & Baldwin, A. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8175-8183.2002 · Cited by 81
Self-citationBilić-Čurčić, I., Kronenberg, M. S., Jiang, X., Bellizzi, J., Mina, M., Marijanović, I., Gardiner, E. M., & Rowe, D. W. (2005) · genesis · doi:10.1002/gene.20156 · Cited by 78
Chen, S., Guttridge, D. C., Tang, E., Shi, S., Guan, K., & Wang, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105335200 · Cited by 71
Self-citationTwist Genes Regulate Runx2 and Bone Formation
Kronenberg, H. M. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00069-3 · Cited by 57
Estrogen receptor ligands in the control of pathogenic inflammation.
Harnish, D. C. (2006) · PubMed · Cited by 36
Yang, F., Yamashita, J., Tang, E., Wang, H., Guan, K., & Wang, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2446 · Cited by 34
Self-citationWnt Antagonism in Multiple Myeloma: A Potential Cause of Uncoupled Bone Remodeling
Pearse, R. N. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0648 · Cited by 15
Cited by
Khosla, S., Oursler, M. J., & Monroe, D. G. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.03.008 · Cited by 943
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Promoting tissue regeneration by modulating the immune system
Julier, Z., Park, A. J., Briquez, P. S., & Martino, M. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.056 · Cited by 766
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., & Serrano, M. (2010) · Nature Communications · doi:10.1038/ncomms1001 · Cited by 612
Metadata
- Authors
- Chang, J., Wang, Z., Tang, E., Fan, Z., McCauley, L., Franceschi, R., Guan, K., Krebsbach, P. H., & Wang, C.-Y.
- Venue
- Nature Medicine
- Published
- 2009-05-17
- Volume
- 15
- Issue
- 6
- Pages
- 682-689
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1967937835
- Cited by
- 481
- References
- 39
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
